Medtech titan Boston Scientific enrolls the first patient in a clinical registry evaluating the Vercise deep brain stimulation system for Parkinson’s disease. Boston Scientific (NYSE:BSX) kicked off a new registry evaluating deep brain stimulation in treatment of Parkinson’s disease. The medtech titan announced this week that it enrolled the 1st of up to 300 patients slated for participation in the registry.
Help employers find you! Check out all the jobs and post your resume.
